Cilo Cybin Holdings Limited, or simply Cilo Cybin, is aiming to revolutionize how we approach health, performance, and longevity. But what makes this IPO stand out, and why should investors take note? Let's dive in.
Why the Biotech Sector?
Choosing to focus on biotech is a smart move for Cilo Cybin. Here's why: biotech uses living things to make medicines, which is a different approach from traditional drug companies that use chemicals. This method can lead to new kinds of treatments and is part of a market that's growing really fast. In fact, experts predict that the biotech market will jump from $1.4 billion in 2023 to $3.2 billion by 2030, growing at a rate of 12.8% each year.
What's Happening?
Cylo Cybin is gearing up for an Initial Public Offering (IPO), aiming to raise R7,101,791. They're planning to join the Altx market of the Johannesburg Stock Exchange (JSE).
Why You Should Consider Investing?
Investing in Cilo Cybin means getting in on the ground floor of several high-growth sectors:
Cannabis and Psychedelics: With a history of operation since 2018, Cilo Cybin has emerged as a leader in the cannabis market, aiming to become a global branded player. The medical cannabis market alone is expected to reach USD 40.48 billion by 2032, complemented by a psychedelic drugs market forecasted to hit USD 12 billion by 2035.
Holistic Health Solutions: Beyond cannabis, Cilo Cybin's vision includes a broader range of holistic health solutions, emphasizing the potential of psychedelics in mental health treatment. The Asia Pacific region, in particular, shows promise, with a projected CAGR of over 10.1% for the psychedelic mushroom market through 2032.
Key Dates
Opening Date: 26 February 2024, 09:00
Closing Date: 12 April 2024, 12:00
Internal Close: 11 April 2024, 00:00
Final Results: 17 April 2024
It's an opportunity for investors to get in on the ground floor with a promising company, with all the details laid out transparently for a clear and straightforward investment process.
Learn more
To look for new listings on our platform, select the stack menu button on the top-left hand side of your account. Under the My Investments option, select New Listings. Here you should find the latest instruments or companies available on initial public offer.
Want to know more about the latest news?
Any opinions, news, research, reports, analyses, prices, or other information contained within this research is provided by an external contributor as general market commentary and does not constitute investment advice for the purposes of the Financial Advisory and Intermediary Services Act, 2002. First World Trader (Pty) Ltd t/a EasyEquities (“EasyEquities”) does not warrant the correctness, accuracy, timeliness, reliability or completeness of any information (i) contained within this research and (ii) received from third party data providers. You must rely solely upon your own judgment in all aspects of your investment and/or trading decisions and all investments and/or trades are made at your own risk. EasyEquities (including any of their employees) will not accept any liability for any direct or indirect loss or damage, including without limitation, any loss of profit, which may arise directly or indirectly from use of or reliance on the market commentary. The content contained within is subject to change at any time without notice.
Any opinions, news, research, reports, analyses, prices, or other information contained within this research is provided by an employee of EasyEquities an authorised FSP (FSP no 22588) as general market commentary and does not constitute investment advice for the purposes of the Financial Advisory and Intermediary Services Act, 2002. First World Trader (Pty) Ltd t/a EasyEquities (“EasyEquities”) does not warrant the correctness, accuracy, timeliness, reliability or completeness of any information (i) contained within this research and (ii) received from third party data providers. You must rely solely upon your own judgment in all aspects of your investment and/or trading decisions and all investments and/or trades are made at your own risk. EasyEquities (including any of their employees) will not accept any liability for any direct or indirect loss or damage, including without limitation, any loss of profit, which may arise directly or indirectly from use of or reliance on the market commentary. The content contained within is subject to change at any time without notice.
From how-to’s to whos-whos you’ll find a bunch of interesting and helpful stuff in our collection of videos. Our knowledge base is jam packed with answers to all the questions you can think of.